Стр. 174 - 2

165
A. Vantieghem et al. // FEBS Lett. − 2003. − Vol. 540, № 1-2.
− P. 125−132.
415.Ultraviolet exposure as the main initiator of p53 mutations in basal cell
carcinomas from psoralen and ultraviolet A – treated patients with psoriasis
/ H. Seidl, H. Kreimer-Erlacher, B. Bäck et al. // J. Invest. Dermatol.
− 2001. − Vol. 117, № 2. − P. 365–370.
416.Ultraviolet-B-induced G1 arrest is mediated by downregulation of cyclin–
dependent kinase 4 in transformed keratinocytes lacking functional p53 /
A.L. Kim, M. Athar, D.R. Bickers, J. Gautier // J. Invest. Dermatol. − 2002.
− Vol. 118, № 5. − P. 818–824.
417.UV-induced skin damage / M. Ichihashi, M. Ueda, A. Budiyanto et al. //
Toxicology. − 2003. − Vol. 189, № 1-2. − P. 21–39.
418.Van de Kerkhof P.C. An update on vitamin D3 analogues in the treatment
of psoriasis / P.C. van de Kerkhof // Skin Pharmacol. Appl. Skin Physiol.
− 1998. − Vol. 11, № 1. − P. 2–10.
419.Van der Fits L. Psoriatic lesional skin exhibits an aberrant expression
pattern of interferon regulatory factor–2 (IRF–2) / L. van der Fitz, L.I. van
der Wel, J.D. Laman et al. // J. Pathol. − 2003. − Vol. 199, № 1.
− P.107−114.
420.Victor F.C. TNF-alpha and apoptosis: implications for the pathogenesis and
treatment of psoriasis / F.C. Victor, A.B. Gottlieb // J. Drugs Dermatol.
− 2002. − Vol. 1, № 3. − P. 264−275.
421.Vollmer S. Dominant lesional T cell receptor rearrangements persist in
relapsing psoriasis but are absent from nonlesional skin: evidence for a sta-
ble antigen–specific pathogenic T cell response in psoriasis vulgaris /
S.Vollmer, A. Menssen, J.C. Prinz // J. Invest. Dermatol. − 2001.
− Vol. 117, № 5. − P.1296-1301.
422.Vollmer S. T-lymphocytes derived from skin lesions of patients with
psoriasis vulgaris express a novel cytokine pattern that is distinct from that
of T-helper type1 and T-helper type2 cells / S. Vollmer, A. Menssen,
P. Trommler et al. // Eur. J. Immunol. – 1994. – Vol. 24, № 10.
– Р. 2377-2382.
423.Vrzogic P. Effect of naphthalan on epidermal proliferation activity and
CD3, CD4, and CD8 lymphocyte count / P. Vrzogic, J. Jakic-Razumovic,
A. Pasic // Acta Dermatovenerol. Croat. − 2003. − Vol. 11, № 2. − P.65-69.
424.Weigl B.A. Immunoregulatory mechanisms and stress hormones in
psoriasis // Int J. Dermatol. – 1998. – Vol. 37, № 11. – P. 880.
425.Weinstein I. Relevance of cyclin D1 and other molecular markers to cancer
chemoprevention / I.B.Weinstein // J. Cell Biochem. Suppl. – 1996.
– Vol. 25. – P. 23–28.